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Abstract Mutation of the Trp92 that is known to lie within the
active site of the photoprotein obelin from Obelia longissima,
results in a shift of the bioluminescence color from blue
(Vmax = 485 nm) to violet. The corrected spectrum shows a new
band with Vmax = 410 nm now contributing equally to the one at
longer wavelength. The crystal structure of this W92F obelin
determined at 1.72 Aî resolution shows that there is no significant
change in the dimensions of the active site between WT obelin
(recombinant Ca2+-regulated photoprotein from Obelia longis-
sima) and the mutant. It is proposed that the bioluminescence
spectral shift results from removal of a hydrogen bond from the
indole of W92 nearby a hydroxyl belonging to the 6-phenyl
substituent of the substrate coelenterazine. Propagation of this
change through a conjugated bond system in the excited state of
the product coelenteramide affects the coupling of the N1-
position and the hydrogen-bonded Y138. ß 2001 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Calcium-regulated photoproteins are found in the marine
bioluminescent coelenterates [1], the most well-known being
Aequorin, from the bioluminescent jelly¢sh Aequorea [2].
They are named because it only requires the addition of
Ca2 to trigger the light reaction, with the emission of bio-
luminescence of blue to blue^green color. Their biolumines-
cence spectral distributions are broad with maxima depending
on the species in the range 465^495 nm. It had been proposed
that the lack of any substrate requirement for the light reac-
tion is because the protein contains an imidazopyrazinone
derivative named ‘coelenterazine’ tightly bound within the
protein’s active site and as a stabilized peroxide derivative
(I). Many chemical and biochemical studies have established
the reaction to be an oxidative decarboxylation of this per-
oxycoelenterazine with the exergonicity deposited into the ¢rst
electronic state of the product, coelenteramide (Scheme 1).
Fluorescence studies of coelenteramide and analogues have
shown that several ionic species can exist, a neutral species (II)
with £uorescence spectral maximum around 400 nm, the
amide monoanion (III) around 450 nm, a phenolate anion
(IV) 480^490 nm, and other anionic species with maxima at
longer wavelengths [3]. Small variations are also introduced
by solvent dielectric constant and solvent viscosity changes.
The general consensus is that the excited state III is the source
of the bioluminescence spectrum but in obelin (Vmax = 485 nm)
there is a small band at 400 nm [4] evidently from the excited
II [3]. Part of the identifying evidence for III as the primary
excited state therefore was in the case of aequorin, a close
match between its bioluminescence spectrum (Vmax = 465 nm)
and the £uorescence of the protein-bound product. However
for other photoproteins such as obelin, the product £uores-
cence is not the same and is at longer wavelength than the
bioluminescence [4]. It is suggested that the Ca2-discharged
obelin £uorescence is from IV, as it is matched by the £uo-
rescence of coelenteramide in certain basic apolar solvents [3].
Very recently the three-dimensional structures of two re-
combinant photoproteins have been determined, aequorin at
resolution 2.3 Aî [5], and obelin from the hydroid Obelia long-
issima, at resolutions 1.7 [6] and 1.1 Aî [7]. Both photoproteins
exhibit spatial structure characteristics of the super-family of
Ca2-regulated proteins, four helix^turn^helix motifs, but
only three motifs are Ca2-binding EF-hands. Of considerable
importance for mechanistic study is that these structures show
the substrate stabilized within the active site. Both protein
structures indicate that the coelenterazine is substituted at
the C2-position. In the aequorin crystal, weak electron density
at this C2-position is consistent with the presence of a peroxy
group but there is clearly only one oxygen atom in both obe-
lin structures. It has been suggested that the latter represents
the substrate prior to oxygen addition, perhaps bound as a
hydrate [7].
Ohmiya et al. [8] produced a number of Trp to Phe mutants
of aequorin and found that one of them, W86F, showed a
bioluminescence emission with the 400-nm band enhanced, i.e.
a contribution to the emission from II. We show here that the
equivalent mutation in obelin, W92F, produces an even great-
er enhancement and that there is no signi¢cant change in the
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dimensions of the active site between WT obelin and the mu-
tant. The spatial structure now provides a rational basis for
explaining the enhancement of the 400-nm bioluminescence. It
is proposed that the bioluminescence spectral shift results
from removal of the in£uence of hydrogen bonding from
the indole of W92 which lies nearby the hydroxyl belonging
to the 6-phenyl substituent of the substrate coelenterazine.
2. Materials and methods
2.1. Molecular biology
Site-directed mutagenesis was done on the template pET19-OL8
Escherichia coli expression plasmid carrying the O. longissima wild-
type apo-obelin (herein called WT obelin) [4]. Mutation resulting in
the amino acid change W92F was introduced using the QuickChange
site-directed mutagenesis kit from Stratagene (La Jolla, CA, USA)
according to the manufacturer’s instructions. Two complementary
oligonucleotides containing the desired mutations were the sense
primer 5P-CAATTCCTCGATGGATTCAAACAATTAGCG-3P and
antisense primer 5P-CGCCAATTGTTTGAATCCATCGAGGAAT-
TG-3P. The changed nucleotides causing the mutations are underlined.
Plasmid harboring the mutation was veri¢ed by DNA sequence anal-
ysis.
For protein production, the E. coli BL21-Gold cells with the W92F-
obelin plasmid were cultivated with vigorous shaking at 37‡C in LB
medium containing ampicillin and induced with 1 mM isopropyl L-D-
thiogalactopyranoside when the culture reached an OD600 of 0.5^0.6.
After induction, the cultivation was continued for 3 h.
2.2. Protein puri¢cation, crystallization and data collection
W92F obelin was puri¢ed as previously reported [4,9]. The puri¢ed
protein was concentrated to approximately 8^10 mg/ml, desalted on a
BioGel P2 column equilibrated with 1 mM EDTA, 10 mM Na/K
phosphate bu¡er, pH 7.3, and concentrated again to approximately
the same concentration. Protein was homogeneous according to LC-
Electrospray Ionization Mass Spectrometry and the mass was in ex-
cellent agreement with that calculated from sequence excluding Met1,
as also observed for WT obelin [10]. Protein concentration was deter-
mined with the Bio-Rad DC Protein Assay Kit with bovine serum
albumin as a protein standard.
W92F obelin was crystallized under conditions similar to WT obe-
lin [7] by the hanging drop vapor di¡usion technique at 4‡C. The best
precipitant was a solution containing 18% polyethylene glycol 8000,
50 mM KH2PO4, pH 6.0, with the addition of hexaminecobalt chlo-
ride into the drop. Obelin crystals had a size of about 0.5U0.25U0.25
mm after 10^15 days. Crystals exposed to calcium ion before and after
X-ray irradiation, emit light con¢rming that the crystals consist of an
active photoprotein. A complete di¡raction data set to 1.72 Aî reso-
lution has been collected at 100 K, on a RAXIS IV image plate
detector using MSC blue osmic confocal optics focused 5.0 kW Cu
KK X-rays generated on a Rigaku RU200 rotating anode. The data
were indexed, integrated, and scaled using DENZO/SCALEPACK.
2.3. Re¢nement
The structure was determined by the Molecular Replacement Meth-
od using WT obelin (protein data base entry: 1EL4) as a search
model. The space group is P41212 with unit-cell dimensions
a = b = 53.45 Aî and c = 144.49 Aî . The re¢nement was carried out using
CNS1.0 [11]. The ¢nal R-value is 23.4%. The free R-factor value is
27.6% using 8% re£ection test set. The root-mean-square deviation
(r.m.s.d.) in bond length and angles are 0.005 Aî and 1.1‡ respectively.
Analysis of the Ramachandran plot (PROCHECK) [12] showed that
94% residues are in most favored regions and 6% residues are in
additional allowed regions. No residues are in disallowed or gener-
ously allowed regions. Atomic coordinates have been deposited with
the Protein Data Bank, accession code 1JF2.
2.4. Bioluminescence assay
The bioluminescence emission was measured with a home-made
photometer or a Turner TD-20e luminometer by rapid injection of
10 Wl of the photoprotein solution into the luminometer cell contain-
ing 1 ml of 100 mM CaCl2, 100 mM Tris^HCl, pH 7.0, at room
temperature.
2.5. Spectral measurements
Absorption spectra were obtained with a Hewlett-Packard 8453
UV-visible spectrophotometer. Bioluminescence and £uorescence
spectra were measured with an SLM-8000 spectro£uorometer. Emis-
sion spectra were corrected by reference to the absolute spectral dis-
tribution of quinine sulfate, which was also used as the reference for
the £uorescence quantum yield. The bioluminescence spectra were
measured at 20‡C from the obelin in 1 mM EDTA, 10 mM Tris^
HCl, pH 7.0, and initiated by injection of CaCl2. The concentration of
free calcium was 0.5 WM in order to provide a constant light level
during the spectral scan. The concentration of calcium was calculated
with the MAXICHELATOR program.
3. Results
Fig. 1 shows the bioluminescence emission from W92F obe-
lin mutant together with the £uorescence of the product. The
left panel is the uncorrected bioluminescence spectrum to
demonstrate that the band at shorter wavelength is much
more enhanced than for the W86F aequorin published by
Ohmiya et al. [8]. The right panel shows that after correction,
Scheme 1.
Fig. 1. Bioluminescence and £uorescence spectra. Left panel: Uncor-
rected bioluminescence spectrum (dotted line) from W92F obelin
shows a much enhanced 400-nm contribution over that of aequorin
W86F published by Ohmiya et al. [8]. Right panel: Corrected biolu-
minescence (dotted line) from W92F obelin and £uorescence (solid
line) of the Ca2-discharged protein product (Vmax = 510 nm;
Ex = 350 nm).
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the two bands are about equally intense, the bioluminescence
maxima are at 410 and 470 nm. Probably the longer wave-
length band is the same as for WT obelin (485 nm) only
distorted by the tail of the shorter wavelength band.
The product £uorescence does not correspond to the bio-
luminescence emission (right panel) as also found for WT
obelin (Vmax = 510 nm). For aequorin the £uorescence of the
Ca2-discharged corresponds to the bioluminescence but Oh-
miya et al. [8] did not report on the case with Ca2-discharged
W86F-aequorin.
Fig. 2 shows that the absorption spectra of W92F mutant
and WT obelin have the same maxima, 275 and 460 nm, with
the visible absorbance relative to that at 275 nm being low-
ered in the mutant (F0:1%1 cm at 280 nm is 1.99 and 2.5 for the
W92F and WT obelin, respectively) since one Trp was re-
placed for Phe. The Ca2-discharged proteins also have the
same maxima, at 344 and 278 nm in the presence of Ca2. The
uncorrected excitation maximum of the Ca2-discharged pro-
teins is around 340 nm. The £uorescence emission anisotropy
is 0.33 and constant over the 340-nm excitation band indicat-
ing that the £uorophore is rigidly bound to the protein.
The overall structure of the W92F mutant of obelin shows
the same sets of helix^turn^helix motifs as WT obelin, with an
r.m.s.d. between the CK-positions of the two proteins of only
0.525 Aî . Details of the crystallization and structure solution
will be given elsewhere. Of more relevance to the spectral
properties is a comparison of the structures of the coelenter-
azine^oxygen binding site. The electron density map in Fig. 3
shows a relatively weak density around the coelenterazine
C2-position, consistent with the substitution by a peroxy
group the same as observed for aequorin by Head et al. [5],
but in contrast to the single oxygen at this position for the
WT obelin.
Fig. 4 is the substrate in the active site and compares the
distances to the residues forming the binding cavity between
the WT obelin and W92F. Apart from the insertion of a
second oxygen between the C2-position and the Y190, the
mutation produces no signi¢cant change among the other
separations including the two nearby water molecules.
It also needs to be noted that the W92F mutant does not
have signi¢cant di¡erences in the speci¢c activity, in the level
of calcium-independent luminescence, in the temperature
stability, and in the kinetics of coelenterazine binding (data
not shown), in comparison with WT obelin.
4. Discussion
Proteins in this Ca2-regulated super-family, undergo a
conformation change on binding Ca2 and so it can be rea-
sonably supposed that an analogous change is responsible for
triggering the chemical reaction leading to the coelenteramide
excited state from which the bioluminescence emission occurs.
Indeed nuclear magnetic resonance evidence indicates that the
obelin apo-protein can assume several conformations includ-
ing that of obelin itself (with coelenterazine), of the Ca2-dis-
charged protein (with coelenteramide) in the presence of Ca2,
and of the same after removing Ca2 [13]. The biolumines-
cence intensity re£ects the overall reaction rate and this inten-
sity reaches a maximum on the millisecond time scale, a time
su⁄cient for an adjustment of the protein structure, particu-
Fig. 3. Stereoview of the electron density map and substrate structure including residue Y190, within the binding cavity of W92F obelin. There
is su⁄cient electron density around the C2-position of coelenterazine to account for a peroxy substitution. The electron density is weaker here
than over the rest of the molecule as also observed in aequorin by Head et al. [5].
Fig. 2. Absorbance spectra of WT-obelin (dotted line) and W92F
(solid line) both normalized at 280 nm.
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larly if only a minor alteration around the active site is in-
volved.
The problem here is that if we seek an explanation for the
di¡erence in the bioluminescence spectra in structural terms,
we only have the structures of aequorin, obelin and the W92F
obelin mutant, in hand. In the overall structure of W92F
obelin which will be presented in more detail elsewhere, there
are some slight (0.5) displacements of some residues compared
with WT obelin. In the binding cavity however, Fig. 4 shows
that there is no signi¢cant ( þ 0.3 Aî ) dimensional di¡erence
between WT obelin and the W92F mutant. The equivalent
dimensions in aequorin are also nearly the same as these obe-
lins. Therefore, how is the strong emission from II so favored
in the W92F mutant? Besides the appearance of the C2-per-
oxide substitution in W92F mutant, the controlling factor
must be in the presence or absence of the Trp92 hydrogen
bond to the p-hydroxy group of the 6-phenyl substituent
(Fig. 4).
Studies of the chemiluminescence in an aprotic medium as a
model, indicate that III is the primary excited state produced
by the bioluminescence reaction [14,15] (Scheme 1). In the
ground state an amide hydrogen is not acidic but in the pro-
tein binding site the protonation rate of III might not be
competitive with the rate of £uorescence transition. But in
fact the bioluminescence spectrum from obelin but not
aequorin, already shows a small contribution at 400 nm, iden-
ti¢ed as emission from II. The excited amide presumably re-
ceives its proton from the proximate hydroxy group of Y138.
The W92F change removes the proton coupling via the hydro-
gen bond from the indole in the vicinity of the hydroxy of the
6-phenyl. Because the conjugation in the coelenteramide ex-
tends from this hydroxy to the N1-position, it would not be
surprising to ¢nd an in£uence on the proton coupling between
the N1 and Y138 hydroxyl. This proposition does not require
any dimensional change although we have no knowledge of
how the protein structure might have changed by the time the
initially excited coelenteramide is formed. In the aequorin
study of a number of Trp mutants, only the equivalent
W86F mutant showed a clear bioluminescence spectral con-
tribution from II although it is much smaller than in the case
of W92F-obelin.
For aequorin the Ca2-discharged protein has a £uores-
cence spectrum corresponding to the bioluminescence. This
would occur if there was a pK shift of the excited coelenter-
amide within the binding site to favor dissociation of the
amide proton. However, for both Ca2-discharged WT obelin
and W92F mutant the ¢nal state has a green £uorescence,
maximum 510 nm. For obelin therefore, there must be a fur-
ther structural change going to the ¢nal product state. Con-
sequently, a direct spectroscopic examination of the amide
anion in Ca2-discharged obelins is not experimentally acces-
sible but could be feasible for the Ca2-discharged W86F
aequorin.
Further structural and spectroscopic investigation of photo-
protein mutants are planned to follow up these ideas.
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